Advancing RWE Use in Support of Precision Medicines
Murray Aitken (IQVIA)
Using RWE to Inform Value-Based Agreements: European Experience & Opportunities for Canada
Dr. Michael Seewald (AstraZeneca)
Value by Design: The Potential of RWE in Sustainable Patient Access
Dr. Christopher McCabe (Institute of Health Economics)
Followed by Panel Discussion –
Value Based Agreements and RWE Frameworks
Murray Aitken (IQVIA)
Dr. Michael Seewald (AstraZeneca)
Dr. Christopher McCabe (Institute of Health Economics)
Leigh Funston (AstraZeneca) - Discussant
Anne Marie Wright (ESI) - Conference Facilitator